Generic Parkinson's drug shows promise in healthy volunteer study

This study tested whether a new generic version of pramipexole extended-release tablets works the same as the brand-name drug (MIRAPEX ER) in 49 healthy Chinese adults. Participants took a single dose of either the generic or brand-name drug, and researchers measured drug levels in their blood to check for bioequivalence. The study also monitored for side effects. This is a Phase 1 trial, meaning it focused on safety and how the body processes the drug, not on treating a disease.